SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 137 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,266,324 | +329.0% | 431,565 | +523.9% | 0.02% | +325.0% |
| Q1 2023 | $1,460,849 | -19.6% | 69,169 | -26.8% | 0.00% | -33.3% |
| Q2 2022 | $1,818,000 | -53.3% | 94,474 | -57.8% | 0.01% | -45.5% |
| Q1 2022 | $3,894,000 | -44.9% | 224,058 | -30.6% | 0.01% | -26.7% |
| Q4 2021 | $7,064,000 | +236.1% | 322,720 | +193.4% | 0.02% | +200.0% |
| Q3 2021 | $2,102,000 | +9.0% | 109,980 | -2.1% | 0.01% | +25.0% |
| Q2 2021 | $1,929,000 | -64.3% | 112,339 | -53.5% | 0.00% | -71.4% |
| Q1 2021 | $5,398,000 | -59.2% | 241,414 | -59.4% | 0.01% | -63.2% |
| Q4 2020 | $13,230,000 | +295.4% | 594,871 | +162.4% | 0.04% | +216.7% |
| Q3 2020 | $3,346,000 | -36.4% | 226,689 | -36.1% | 0.01% | -53.8% |
| Q2 2020 | $5,258,000 | +639.5% | 354,811 | +447.5% | 0.03% | +333.3% |
| Q1 2020 | $711,000 | +44.2% | 64,805 | +15.3% | 0.01% | +500.0% |
| Q4 2019 | $493,000 | +273.5% | 56,194 | +216.9% | 0.00% | – |
| Q3 2019 | $132,000 | +120.0% | 17,735 | +31.5% | 0.00% | – |
| Q4 2018 | $60,000 | -67.7% | 13,487 | -41.5% | 0.00% | -100.0% |
| Q3 2018 | $186,000 | -31.4% | 23,065 | -25.4% | 0.00% | 0.0% |
| Q4 2017 | $271,000 | – | 30,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |